PPA
FBRX icon

Parametric Portfolio Associates’s Forte Biosciences FBRX Stock Holding History

Parametric Portfolio Associates’s Portfolio FBRX Stock Details FBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$100K Sell
2,739
-4,250
-61% -$161K ﹤0.01% 3561
2021
Q4 		$374K Buy
6,989
+2,543
+57% +$171K ﹤0.01% 3189
2021
Q3 		$329K Buy
4,446
+3,644
+454% +$2.02M ﹤0.01% 3266
2021
Q2 		$674K Buy
+802
New +$723K ﹤0.01% 2955
2020
Q2 		– Sell
-95
Closed -$44K – 3949
2020
Q1 		$44K Sell
95
-265
-74% -$104K ﹤0.01% 3847
2019
Q4 		$72K Buy
+360
New +$81.6K ﹤0.01% 3901
2019
Q3 		– Sell
-30
Closed -$75K – 3955
2019
Q2 		$75K Buy
+30
New +$89K ﹤0.01% 3871

Other funds holding FBRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Parametric Portfolio Associates's FBRX Position: Q1 2022 in Review

Parametric Portfolio Associates reduced its Forte Biosciences (FBRX) stake by 61% in Q1 2022, selling an estimated $161K and leaving 2,739 shares worth $100K. The position accounts for ﹤0.01% of the portfolio, ranked #3561.

Parametric Portfolio Associates first reported a position in FBRX in Q2 2019 and has held it in 7 quarters since. The position peaked at $674K in Q2 2021. 52 funds tracked by Wall St. Rank hold FBRX as of Q1 2022.

  • Parametric Portfolio Associates held 2,739 shares of Forte Biosciences worth $100K as of Q1 2022.
  • Parametric Portfolio Associates sold 4,250 Forte Biosciences shares in Q1 2022, an estimated $161K.
  • Forte Biosciences made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #3561 holding.
  • Parametric Portfolio Associates first reported a position in Forte Biosciences in Q2 2019 and has held it in 7 quarters since.
  • Parametric Portfolio Associates's Forte Biosciences position peaked at $674K in Q2 2021.
  • 52 funds tracked by Wall St. Rank held Forte Biosciences as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.